By Daniella Parra Acumen Pharmaceuticals said it will present new research on its Alzheimer’s treatment candidate at the International Conference on Alzheimer’s and Parkinson’s Diseases 2026 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results